| Product | Threshold | Evidence |
|---|---|---|
| pRBCs -general RESTRICTIVE | Hgb < 7 g/dL | TRICC, 1999: restrictive (7) non-inferior to liberal (10) in ICU. TRICS-III, 2017: confirmed in cardiac surgery. |
| pRBCs -ACS | Hgb < 8 g/dL (or symptomatic anemia) | REALITY, 2021: restrictive (8) vs liberal (10) -non-inferior for 30-day MACE in MI. |
| pRBCs -active bleeding | Hgb < 7โ8, but transfuse to symptoms/hemodynamics | MTP: 1:1:1 ratio PROPPR, 2015 (pRBC:FFP:platelets). Don't wait for lab values in massive hemorrhage. |
| Platelets -general | < 10,000 (prophylactic) | Higher thresholds for active bleeding (< 50K), neurosurgery (< 100K), or procedures. |
| FFP | Active bleeding + INR > 1.5 | 15 mL/kg. Or 4F-PCC for warfarin reversal (faster, less volume). |
| Cryoprecipitate | Fibrinogen < 100โ150 (DIC, massive transfusion) | 10 units raises fibrinogen ~50โ70 mg/dL. Key product in DIC. |
| Product | Contains | Expected Effect | Special Considerations |
|---|---|---|---|
| pRBCs | Red blood cells in additive solution | โ Hgb ~1 g/dL per unit | Type & screen required. Irradiate if immunocompromised (prevent TA-GVHD). CMV-negative or leukoreduced for transplant candidates. |
| Platelets | Platelets (apheresis or pooled) | โ 30,000โ50,000 per unit | ABO-compatible preferred. Room temperature storage (not refrigerated). 5-day shelf life. Highest bacterial contamination risk of all blood products. |
| FFP | All clotting factors | โ factor levels ~20โ30% | ABO-compatible required. Thaw time ~30 min. Volume ~250 mL/unit (risk of TACO). |
| Cryoprecipitate | Fibrinogen, Factor VIII, vWF, Factor XIII | โ fibrinogen ~50โ70 mg/dL per 10 units | Key for DIC, massive transfusion, factor XIII deficiency. Pooled (10 units = 1 dose). |
| Reaction | Timing | Features | Management | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute hemolytic (ABO mismatch) | Minutes | Fever, flank pain, dark urine, hypotension, DIC. Most dangerous. Usually clerical error. | STOP immediately. IVF (prevent renal failure), send direct Coombs + repeat type & screen. Supportive ICU care. | ||||||||||||||||||
| Febrile non-hemolytic (FNHTR) | 1โ6 hours | Fever, rigors. Most common reaction. Cytokines from donor WBCs. | Stop, rule out hemolytic. Acetaminophen. Leukoreduced products prevent recurrence. | ||||||||||||||||||
| Allergic (mild) | During | Urticaria, pruritus. No fever or hemodynamic changes. | Stop temporarily. Diphenhydramine 25โ50 mg IV. Can resume slowly if mild. | ||||||||||||||||||
| Anaphylactic | Minutes | Hypotension, bronchospasm, angioedema. Often in IgA-deficient patients (anti-IgA antibodies). | Epinephrine 0.3โ0.5 mg IM. IVF, steroids, bronchodilators. Future: washed or IgA-deficient products. | ||||||||||||||||||
| TRALI | โค 6 hours | Acute respiratory distress + bilateral infiltrates + hypoxia within 6h. No volume overload. Caused by donor antibodies activating recipient neutrophils in lungs. | Supportive (Oโ, ventilation). Diuretics do NOT help (not a volume issue). Usually resolves 48โ96h. Report to blood bank. | ||||||||||||||||||
| TACO | โค 6 hours | Volume overload โ pulmonary edema, HTN, JVD. Distinguished from TRALI by: elevated BNP, response to diuretics, hypertension. | Diuretics. Slow transfusion rate for future products
๐ Overview
Overview
Blood product transfusion is one of the most common inpatient procedures. Restrictive thresholds (Hgb < 7) are standard for most patients [TRICC, 1999; TRISS, 2014] -liberal transfusion does not improve outcomes and may worsen them. In acute coronary syndrome, threshold is Hgb < 8. Always transfuse 1 unit at a time and recheck before ordering more. Massive transfusion protocol (MTP): 1:1:1 ratio of pRBC:FFP:platelets + TXA 1g IV [CRASH-2, 2010; PROPPR, 2015]. Key reactions to recognize: TRALI (non-cardiogenic pulmonary edema, normal BNP, within 6h) vs TACO (volume overload, elevated BNP, responds to diuretics). Stop transfusion immediately for any suspected reaction. ๐งช Workup
Workup
๐จ Management
Management
๐ On Rounds
How do you distinguish TRALI from TACO?
Both present with respiratory distress + bilateral infiltrates within 6h of transfusion. TRALI: non-cardiogenic pulmonary edema (BNP normal or low, hypotension, no JVD, does NOT respond to diuretics). Caused by donor antibodies. TACO: cardiogenic volume overload (BNP elevated, hypertension, JVD, responds to diuretics). Risk factors: CHF, CKD, rapid infusion rate, multiple units. Key distinguisher: give furosemide. If they improve โ TACO.
Why Hgb 7, not 10?
TRICC, 1999 randomized ICU patients to restrictive (Hgb 7) vs liberal (Hgb 10) transfusion. Restrictive was non-inferior for 30-day mortality and had fewer cardiac events. Multiple subsequent trials confirmed this across cardiac surgery TRICS-III, 2017, GI bleed Villanueva, 2013, and hip surgery FOCUS, 2011.
What is TRALI and how do you differentiate it from TACO?
Both present with respiratory distress during/after transfusion, but treatment is opposite. TRALI (Transfusion-Related Acute Lung Injury): non-cardiogenic pulmonary edema. Onset within 6h. Bilateral infiltrates on CXR. NO signs of volume overload (BNP normal/low, no JVD, no S3). Due to donor antibodies activating recipient neutrophils โ capillary leak. Treatment: supportive (Oโ, intubation if needed, NO diuretics).
What is the transfusion threshold for most hospitalized patients?
Restrictive threshold: Hgb < 7 g/dL for most hospitalized patients. TRICC, 1999 and TRISS, 2014: restrictive (Hgb < 7) was non-inferior to liberal (Hgb < 10) for mortality. Liberal transfusion did NOT improve outcomes and increased complications. Exception: Hgb < 8 for ACS/active cardiac ischemia (the MINT trial MINT, 2023 suggested possible benefit, though not definitive).
โ How do you differentiate TRALI from TACO?
TRALI = non-cardiogenic pulmonary edema. Normal BNP, bilateral infiltrates within 6h, no fluid overload signs, does NOT respond to diuretics. Supportive care only -resolves 48-72h. TACO = volume overload. Elevated BNP, responds to furosemide, often hypertensive. Prevention: slow transfusion rate, furosemide between units in HF/CKD patients.
โ What is the expected hemoglobin rise per unit of pRBC transfused?
~1 g/dL per unit in a 70 kg adult. If the post-transfusion Hgb rise is less than expected, consider: (1) ongoing hemorrhage, (2) hemolysis (check Coombs, LDH, haptoglobin), (3) hypersplenism, (4) volume overload diluting the measurement, (5) lab draw from a diluted line.
โ When do you give cryoprecipitate and what does it contain?
Cryoprecipitate contains: fibrinogen (most important), Factor VIII, Factor XIII, vWF, and fibronectin. Give when fibrinogen < 100-150 mg/dL (DIC, massive transfusion, post-thrombolytics). Dose: 10 units (1 pool) raises fibrinogen ~70 mg/dL. In massive hemorrhage, check fibrinogen early and replace aggressively -it is the first factor to become critically depleted.
โ What is a delayed hemolytic transfusion reaction (DHTR)?
DHTR occurs 3-14 days after transfusion due to anamnestic antibody response (patient was previously sensitized but antibody titer dropped below detection). Presents with: unexplained Hgb drop, new jaundice, dark urine, positive DAT. Especially dangerous in SCD patients -can cause hyperhemolysis (destruction of both transfused AND native RBCs). Prevention: extended phenotype matching.
โ What does TXA do and when is it indicated in massive hemorrhage?
Tranexamic acid (TXA) inhibits fibrinolysis by blocking plasmin. Give 1g IV within 3 hours of hemorrhage onset -later administration may be harmful. Evidence: CRASH-2, 2010 -reduced mortality in trauma. WOMAN, 2017 -reduced death from postpartum hemorrhage. No benefit shown in GI bleeding HALT-IT, 2020. Include in all massive transfusion protocols.
Clinical Examples
๐ Case 1, Acute Hemolytic Transfusion Reaction
Patient: 62M receiving unit of pRBCs for Hgb 6.2. Within 15 min: rigors, fever 39.8ยฐC, severe flank pain, dark urine. BP 82/48. Nursing notes: unit labeled "type A" but patient is "type O." Key findings: ABO-incompatible transfusion, the most dangerous transfusion reaction. Patient (type O) has preformed anti-A antibodies โ immediate intravascular hemolysis โ DIC, shock, renal failure. Almost always a clerical/labeling error. Management:
Teaching point: Acute hemolytic reactions are almost always human error, wrong blood to wrong patient. The bedside nurse check (patient ID + unit label + blood bank tag) is the last line of defense. Two-person verification at bedside prevents this lethal error. ๐ Case 2, TRALI vs TACO
Patient: 75F with HFrEF (EF 30%), received 2 units pRBCs for Hgb 6.8 (GI bleed). 4 hours after second unit: acute dyspnea, SpOโ 84%, bilateral crackles, HTN (180/95). CXR: bilateral pulmonary infiltrates. BNP 2400. Key findings: Elevated BNP + hypertension + responds to diuresis = TACO (transfusion-associated circulatory overload), NOT TRALI. TRALI would have normal BNP, hypotension, and would NOT respond to furosemide. This patient's underlying HF + rapid transfusion โ volume overload. Management:
Teaching point: The BNP is the best discriminator: TACO = elevated BNP (volume overload). TRALI = normal BNP (capillary leak). When in doubt, give furosemide, if the patient improves, it's TACO. TACO is now more common than TRALI since leukoreduction reduced TRALI incidence. ๐ Case 3, Massive Transfusion Protocol
Patient: 32F with ruptured ectopic pregnancy, HR 140, BP 68/30, Hgb 4.2. Actively hemorrhaging. MTP activated. Key findings: Class IV hemorrhagic shock (> 40% blood volume loss). Massive transfusion protocol (MTP) = โฅ 10 units pRBCs in 24h or โฅ 4 units in 1h. Goal: 1:1:1 ratio (pRBC:FFP:platelets) per PROPPR trial. Management:
Teaching point: The biggest mistakes in massive transfusion: (1) giving crystalloid instead of blood (dilutes coagulation factors), (2) forgetting calcium replacement (citrate toxicity โ cardiac arrest), (3) not checking fibrinogen early (depletes before other factors). Resuscitate with blood, not saline. ๐ฃ Sample Presentation
One-Liner
"Mr. Davis is a 68-year-old who developed rigors, fever 39.2ยฐC, and back pain 20 minutes into a pRBC transfusion. BP dropped from 130/80 to 88/52. Transfusion stopped immediately."
Key Points to Cover on Rounds
Suspected acute hemolytic transfusion reaction (fever + hypotension + back pain during transfusion). Immediate actions: (1) transfusion STOPPED, (2) IV access maintained with NS, (3) patient ID rechecked against blood product -mismatch identified (wrong unit hung). Reaction workup sent: repeat type & screen, direct Coombs (DAT), free hemoglobin, LDH, haptoglobin, UA (hemoglobinuria). Blood bank notified immediately. IVF resuscitation for hypotension. Monitoring for DIC (PT/INR, fibrinogen, D-dimer q4h). Plan: supportive care, if Hgb still needed โ crossmatch new unit with correct sample.
๐ Medications
Blood Products & Transfusion Medications
Premedication
Premedication (acetaminophen 650 mg PO + diphenhydramine 25โ50 mg IV/PO) is only indicated if the patient has had a prior febrile or allergic transfusion reaction. Routine premedication for all transfusions is NOT recommended -it delays the transfusion, adds cost, and does not prevent serious reactions (TRALI, hemolytic). Leukoreduction is more effective than premedication for preventing FNHTR.
โก Summary
Summary
Threshold Hgb < 7 for most [TRICC]. Hgb < 8 for ACS. 1 unit raises Hgb ~1 g/dL. Check after each unit before ordering more. Massive Transfusion MTP: 1:1:1 ratio (pRBC:FFP:plt). TXA 1g IV within 3h [CRASH-2]. Caยฒโบ repletion (citrate in products chelates Ca). Warm products. TRALI vs TACO TRALI: non-cardiogenic edema, normal BNP, no diuretics. TACO: volume overload, elevated BNP, responds to furosemide. BNP is the differentiator. Febrile Reaction Fever + rigors during transfusion. Stop. R/O hemolytic reaction: send DAT, free Hgb, LDH, haptoglobin. Most are benign febrile non-hemolytic reactions. Prevention Irradiate for immunocompromised (prevent TA-GVHD). CMV-negative for CMV-seronegative transplant patients. Slow rate for CHF/elderly (1 unit over 2-4h). Type & Screen Always before transfusion. Emergency: O-negative pRBC (universal donor). Type-specific uncrossmatched next. Full crossmatch safest but takes time. ๐ One Pager
Transfusion Medicine -Quick Reference Card
Print this page (Ctrl/Cmd + P) for a condensed reference card. All tabs will print on the same page for a complete topic summary.
TRANSFUSION MEDICINE -AT A GLANCE
๐ฉธ Thresholds: Hgb < 7 (general), < 8 (ACS). Platelets < 10K (prophylactic). FFP for INR > 1.5 + bleeding.
๐งช Workup: Type & screen, crossmatch, CBC, coags, post-transfusion Hgb 1h after โ see Workup tab โ ๏ธ Reactions: STOP transfusion first. TRALI (normal BNP) vs TACO (elevated BNP) โ see Reactions tab ๐ Products: pRBC, platelets, FFP, cryo, TXA โ see Medications tab ๐ Monitor: Vitals q15min ร 1h, watch for reactions, post-transfusion Hgb ๐ฃ Present: Indication, product, reaction workup โ see Rounds tab ๐ One Pager
Hematology ยท One Pager
Transfusion Medicine
Threshold Hgb < 7 for most. 1:1:1 for MTP. TRALI vs TACO: BNP differentiates. Stop + workup any suspected reaction. Type & screen before all transfusions.
๐งช Thresholds
Hgb < 7 for most patients [TRICC, TRISS]. Hgb < 8 for active cardiac ischemia. Massive hemorrhage: 1:1:1 ratio (pRBC:FFP:plt) + TXA [CRASH-2].
๐จ Reactions
Febrile non-hemolytic (most common): stop, workup, rule out hemolytic. Acute hemolytic: fever + hypotension + back pain โ stop immediately, send DAT, free Hgb, haptoglobin. TRALI: non-cardiogenic edema (normal BNP). TACO: volume overload (high BNP โ furosemide).
๐ Special Products
Irradiated: immunocompromised (prevent TA-GVHD). CMV-negative: CMV-seroneg transplant patients. Leukoreduced: prevent febrile reactions. Washed: severe allergic reactions (IgA deficiency).
๐ Key Drugs
pRBCs1 unit raises Hgb ~1 g/dL FFP10-15 mL/kg (INR correction) Platelets1 unit raises plt ~30-50K TXA1g IV (massive hemorrhage)
โ ๏ธ Pitfalls
RoundsRx ยท Hematology
AABB Guidelines 2016 ยท TRICC ยท TRISS ยท CRASH-2
Related Topics Acute Leukemia (AML / ALL)AmyloidosisAnemia WorkupAnemia WorkupAnticoagulation ManagementChemotherapy Toxicities
© 2026 RoundsRx. All rights reserved. | About | Contact
Unauthorized reproduction, redistribution, or derivative use is prohibited.
VIEW
๐ฉบ Health Check
|